FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.
Rodriguez MS, Mahmoud YD, Vanzulli S, Giulianelli S, Spengler E, Martínez Vazquez P, Burruchaga J, Bushweller J, Lamb CA, Lüthy IA, Lanari C, Pérez Piñero C.
Rodriguez MS, et al. Among authors: mahmoud yd.
Int J Cancer. 2024 Dec 28. doi: 10.1002/ijc.35302. Online ahead of print.
Int J Cancer. 2024.
PMID: 39731522